HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.

Bone Marrow Transplant

Bone Marrow Transplant

We’re here for you. Call us at 844-346-7222 or

find a clinical trial

If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.

30 Clinical Trials
Bone Marrow Transplant N/A Enrolling
nct/study# N/A / BENDAMUSTINE-CART-OUTCOMES

Impact of Bendamustine as an Alternative Lymphodepletion Regimen on Chimeric Antigen Receptor T-Cell Therapy Outcomes

Learn More
Bone Marrow Transplant N/A Enrolling
nct/study# N/A / CD34-REAGENT-SYSTEM-GVHD

This protocol is for the use of CliniMACS CD34 Reagent System in a single patient with relapsed AML. Patient received salvage chemo and planned stem cell boost for cytopenias. Since donor is a haplo, plan is to give CD34 selected cells with some t cell add back.

Learn More
Bone Marrow Transplant N/A Enrolling
nct/study# N/A / GVHD-ROSENSTEIN

Biomarkers and Pathogenesis of Cutaneous Fibrosis

Learn More
Bone Marrow Transplant N/A Enrolling
nct/study# N/A / SIND-31560-IDE-CEL

Single Patient Non-Emergency Use IND of Idecabtagene Vicleucel for Patient PAL

Learn More
Bone Marrow Transplant Phase III Enrolling
nct/study# NCT04293185 / HGB210-JTCC

A Phase 3 Study Evaluating Gene Therapy by Transplantation of Autologous CD34+ Stem Cells Transduced Ex Vivo With the LentiGlobin BB305 Lentiviral Vector in Subjects With Sickle Cell Disease

Learn More
Bone Marrow Transplant N/A Enrolling
nct/study# N/A / SIND-31688-IDE-CEL

Single Patient Non-Emergency Use IND of Idecabtagene Vicleucel for Patient MBM

Learn More

We are here for you

For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.